This week, President Biden announced that, by utilizing the Defense Production Act, the federal government has created an historic agreement between drugmakers Johnson & Johnson and Merck to produce enough COVID-19 vaccines for the entire U.S. adult population by May (months quicker than initially expected). This underscores the ability of the U.S. government to facilitate faster vaccine production, argues Peter Maybarduk of Public Citizen, but that production doesn’t have to be driven by the hunt for profit.
Republish our articles for free, online or in print, under a Creative Commons license.
